General Information of This Metabolic Reaction (MR) (ID:
MR004756) |
Formula |
|
Reactant |
Midostaurin |
Product |
CGP 62221 |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Metabolic Type
|
Oxidation
-
O-demethylation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
References |
1 |
Midostaurin: an emerging treatment for acute myeloid leukemia patients
|
2 |
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth
|
3 |
Midostaurin, a novel protein kinase inhibitor for the treatment of acute myelogenous leukemia: insights from human absorption, metabolism, and excretion studies of a BDDCS II drug. Drug Metab Dispos. 2017 May;45(5):540-555.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.